Showing results (191-200 of 325) with videos related to
Sort By:
Pageof 33
Scientific Reports|April 4, 2025
A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samplesYusuke Atarashi, Jeeeun Kim, Yasuhiro Irino, et al.Bioorganic & Medicinal Chemistry Letters|September 28, 2023
SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leadsArun K Ghosh, Dana Shahabi, Mackenzie E C Imhoff, et al.Antimicrobial Agents and Chemotherapy|May 8, 2019
Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS ComplicationsMasayuki Amano, Pedro Miguel Salcedo-Gómez, Ravikiran S Yedidi, et al.The Journal of Biological Chemistry|December 14, 2001
Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitorsHiroyuki Gatanaga, Yasuhiro Suzuki, Hsinyi Tsang, et al.Scientific Reports|February 9, 2022
Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical applicationSanae Hayashi, Masanori Isogawa, Keigo Kawashima, et al.Mbio|August 17, 2021
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300David A Davis, Haydar Bulut, Prabha Shrestha, et al.The Journal of Biological Chemistry|November 11, 2018
Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversalKouki Matsuda, Takuya Kobayakawa, Kiyoto Tsuchiya, et al.European Journal of Medicinal Chemistry|October 20, 2018
Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors incorporating aminothiochromane and aminotetrahydronaphthalene carboxamide derivatives as the P2 ligandsArun K Ghosh, Ravindra D Jadhav, Hannah Simpson, et al.Antimicrobial Agents and Chemotherapy|February 22, 2018
GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant VariantsNicole S Delino, Manabu Aoki, Hironori Hayashi, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 26, 2022
Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19Yusuke Miyazato, Kei Yamamoto, Yuichiro Nakaya, et al.Pageof 33